首页 > 市场调查报告书 > 製药

感染疾病

胆道结石治疗市场规模、份额和成长分析：按治疗方法、产品类型、适应症、最终用户和地区划分－2026-2033年产业预测

市场调查报告书

商品编码

1973218

胆道结石治疗市场规模、份额和成长分析：按治疗方法、产品类型、适应症、最终用户和地区划分－2026-2033年产业预测

Choledocholithiasis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Endoscopic Procedures, Surgical Procedures), By Product Type (Devices, Consumables), By Indication, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2024年全球胆结石治疗市场价值为4.655亿美元，预计将从2025年的4.8971亿美元成长到2033年的7.3462亿美元。预测期（2026-2033年）的复合年增长率预计为5.2%。

全球胆道结石治疗市场专注于透过先进的诊断和治疗方法来管理胆管结石，其发展主要受人口结构变化和技术进步的驱动。由于胆管结石会引发胆管炎和胰臟炎等併发症，需要快速介入并造成巨大的医疗成本，因此该市场至关重要。从传统外科手术到内视镜逆行性造影(ERCP) 和雷射碎石术等微创技术的转变，彻底改变了治疗方式，缩短了患者的康復时间，并促进了门诊手术的发展。尖端内视镜技术的应用持续推动市场成长，使医疗机构能够在提供有效治疗的同时，最大限度地减少併发症和住院时间。人工智慧技术的进步进一步提高了诊断准确性，简化了工作流程，并改善了患者的治疗效果，最终为市场扩张和创新创造了巨大的机会。

全球胆道结石治疗市场驱动因素

全球胆道结石治疗市场正在成长，这主要得益于内视镜手术的日益普及，因为内视镜手术为治疗该疾病提供了微创选择。医疗机构选择这些技术的原因在于其许多优势，例如降低病患併发症风险和缩短恢復时间。临床医生信心的增强、医疗设备的进步以及广泛的培训倡议，使得内视镜治疗在各种医疗机构中更容易获得，从而促进了其更广泛的应用。从传统开放性手术向内视镜技术的转变，刺激了对专用器械和耗材的需求，推动了临床指南的製定，并鼓励了对手术技能的投资，从而增强了相关治疗方法的市场。

全球胆道结石治疗市场的限制因素

全球胆结石治疗市场受到严格的报销政策的显着影响，这给医疗服务提供者和患者都带来了经济上的不确定性。由于医疗费用补偿不足，医疗服务提供者往往会延后采用先进的治疗技术，转而选择成本较低的治疗方案。因此，患者可能会因为自付费用增加而放弃选择性治疗，最终导致手术数量减少。这种情况也阻碍了製造商投资新产品研发和扩大市场覆盖范围，减缓了创新解决方案的推出，并抑制了整体市场成长。

全球胆道结石治疗市场趋势

全球胆结石治疗市场正经历着向微创手术的显着转变，这主要受临床偏好的改变所驱动，即选择能够提升患者舒适度并缩短康復时间的治疗方案。医院和专科医疗中心正在製定优先考虑内视镜和经皮治疗方法的筹资策略，促使医疗设备製造商更加重视器材的人体工学设计和相容性。此外，医疗保险公司和转诊医生也越来越重视与缩短住院时间相关的治疗效果，从而促进了製造商和医疗服务提供者之间的合作，以优化治疗路径。创新培训计画和旨在推广先进技术的跨学科合作也进一步推动了这一发展趋势。

北美洲
- 我们
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场公司采取的策略
近期市场趋势
企业市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 按细分市场进行企业市占率分析
- 2023-2025年营收年比比较

主要企业简介

Boston Scientific
Medtronic
Olympus Corporation
Cook Medical
Conmed Corporation
Johnson & Johnson
Stryker Corporation
B. Braun Melsungen AG
Abbott Laboratories
Intuitive Surgical
Hologic
Merit Medical Systems
Terumo Corporation
Amgen
Echosens
Siemens Healthineers
Ferring Pharmaceuticals
Inotek Pharmaceuticals
DePuy Synthes
Ethicon

结论与建议

简介目录

Product Code: SQMIG35F2022

Global Choledocholithiasis Treatment Market size was valued at USD 465.5 Million in 2024 and is poised to grow from USD 489.71 Million in 2025 to USD 734.62 Million by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global choledocholithiasis treatment market focuses on managing bile duct stones through advanced diagnostics and therapies, driven by demographic shifts and technological advancements. This market is critical due to the potential complications of obstructing stones, such as cholangitis and pancreatitis, which necessitate timely intervention and significant healthcare costs. The evolution from traditional surgical methods to minimally invasive techniques, including endoscopic retrograde cholangiopancreatography and laser lithotripsy, has revolutionized treatment, reducing recovery times and encouraging outpatient procedures. The adoption of cutting-edge endoscopic technologies continues to spur growth, enabling healthcare providers to deliver effective care while minimizing complications and hospital stays. AI advancements are further enhancing diagnostic accuracy, streamlining workflows, and improving patient outcomes, ultimately creating significant opportunities for market expansion and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Choledocholithiasis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Choledocholithiasis Treatment Market Segments Analysis

Global choledocholithiasis treatment market is segmented by treatment type, product type, indication, end user and region. Based on treatment type, the market is segmented into Endoscopic Procedures, Surgical Procedures and Medical Management. Based on product type, the market is segmented into Devices and Consumables. Based on indication, the market is segmented into Primary Cause and Complications. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Choledocholithiasis Treatment Market

The Global Choledocholithiasis Treatment market is experiencing growth driven by the increasing preference for endoscopic procedures, which provide a less invasive option for managing this condition. Healthcare providers are choosing these techniques due to their associated benefits of reduced patient morbidity and quicker recovery times. Enhanced clinician confidence, advancements in device ergonomics, and extensive training initiatives have facilitated access to endoscopic treatments across various healthcare settings, promoting wider adoption. This transition from traditional open surgery to endoscopic methods is fueling the demand for specialized instruments and consumables, prompting the development of clinical guidelines and encouraging investments in procedural technologies, thereby bolstering the market for related therapies.

Restraints in the Global Choledocholithiasis Treatment Market

The global market for choledocholithiasis treatment is significantly impacted by restrictive reimbursement policies that create financial unpredictability for both healthcare providers and patients. Inadequate compensation for procedures can lead providers to postpone acquiring advanced therapeutic technologies, opting instead for less costly management options. Consequently, patients may be deterred from pursuing elective treatments due to increased out-of-pocket expenses, ultimately resulting in lower procedure volumes. This situation disincentivizes manufacturers from investing in new product development and expanding market offerings, resulting in a slowdown in the adoption of innovative solutions and hindering overall growth within the market.

Market Trends of the Global Choledocholithiasis Treatment Market

The Global Choledocholithiasis Treatment market is experiencing a significant trend towards minimally invasive procedures, as clinical preferences shift towards options that enhance patient comfort and expedite recovery times. Hospitals and specialty centers are tailoring their procurement strategies to prioritize endoscopic and percutaneous solutions, influencing device manufacturers to focus on ergonomics and compatibility in their instruments. Additionally, healthcare payers and referring clinicians are placing greater importance on outcomes associated with shorter hospital stays, leading to collaborative efforts between manufacturers and healthcare providers for optimized treatment pathways. This evolving landscape is further supported by innovative training programs and cross-disciplinary initiatives aimed at facilitating the widespread adoption of these advanced techniques.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Choledocholithiasis Treatment Market Size by Treatment Type & CAGR (2026-2033)

Market Overview
Endoscopic Procedures
- ERCP
- Endoscopic Sphincterotomy
Surgical Procedures
- Cholecystectomy
- Exploratory Laparotomy
Medical Management
- Medications
- Supportive Care

Global Choledocholithiasis Treatment Market Size by Product Type & CAGR (2026-2033)

Market Overview
Devices
- Biliary Stents
- Lithotripsy Devices
Consumables
- Surgical Supplies
- Diagnostic Kits

Global Choledocholithiasis Treatment Market Size by Indication & CAGR (2026-2033)

Market Overview
Primary Cause
- Gallstones
- Strictures
Complications
- Cholangitis
- Pancreatitis

Global Choledocholithiasis Treatment Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Choledocholithiasis Treatment Market Size & CAGR (2026-2033)

North America (Treatment Type, Product Type, Indication, End User)
- US
- Canada
Europe (Treatment Type, Product Type, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment Type, Product Type, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment Type, Product Type, Indication, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment Type, Product Type, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conmed Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intuitive Surgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Echosens
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inotek Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DePuy Synthes
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Conclusion & Recommendations

02-2729-4219

+886-2-2729-4219

License/价格

胆道结石治疗市场规模、份额和成长分析：按治疗方法、产品类型、适应症、最终用户和地区划分－2026-2033年产业预测

Choledocholithiasis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Endoscopic Procedures, Surgical Procedures), By Product Type (Devices, Consumables), By Indication, By End User, By Region - Industry Forecast 2026-2033

目录

介绍

调查方法

执行摘要

市场动态及展望

市场考察

全球胆道结石治疗市场规模：依治疗方法及复合年增长率划分（2026-2033 年）

全球胆道韧带治疗市场规模：依产品类型及复合年增长率划分（2026-2033 年）

全球胆结石治疗市场规模：依适应症和复合年增长率（2026-2033 年）划分

全球胆道结石治疗市场规模：按最终用户和复合年增长率划分（2026-2033 年）

全球胆道结石治疗市场规模及复合年增长率（2026-2033）